Vitamin D and Inflammatory Markers of Cardiovascular Disease in African Americans With Type 2 Diabetes
Vitamin D and Inflammatory Markers of Cardiovascular Disease in African Americans With Type 2 Diabetes
Recent clinical trials in non diabetics showed that vitamin D supplementation markedly
 reduced serum levels of C-reactive protein (CRP), interleukin-6, and tissue matrix
 metallo-proteinases. Our study objective is to evaluate if administration of vitamin D in
 African Americans with hypovitaminosis D and DM Type 2 decreases serum levels of
 inflammatory/thrombotic markers such as CRP: Highly Sensitive C Reactive Protein.
Other questions in our study: In diabetic African American patients,

 1. Prevalence of vitamin D deficiency?

 2. Correlation/relationship between vitamin D levels, Calcium level, parathyroid hormone
 (PTH) and Inflammatory markers

 Setting: All visits will take place at the Fantus Diabetes Clinic.
Inclusion Criteria:

 -  African Americans

 -  DM type 2

 Exclusion Criteria:

 -  symptomatic vitamin D deficiency

 -  hypocalcemia

 -  hypercalcemia

 -  malabsorption

 -  liver disease

 -  patients with creatinine > 1.5. (CKD >/= 3)

 -  pregnancy